Testing effectiveness (Phase 2)Study completedNCT00702884
What this trial is testing
Sunitinib in Treating Patients With Relapsed or Refractory Esophageal or Gastroesophageal Junction Cancer
Who this might be right for
Esophageal Cancer
Tony Bekaii-Saab 25